Dow is facing a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson’s disease. The suit claims Dow failed to disclose health risks tied to the product, raising questions around product safety and corporate conduct. Investors are assessing how this legal action could affect NYSE:DOW, including litigation exposure and reputational risk. For investors tracking Dow, the lawsuit comes at a time when the stock is trading at $30.79 and has fallen 14.5% over the past 30 days. Over...
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
321last 24h
2133last 7d
379● bullish (7d)
186● bearish (7d)
204publishers
Simply Wall St.50d agobearish
Dow (DOW) Faces Parkinson’s Lawsuit Over Chlorpyrifos Safety Claims